Clearside Biomedical Inc (NAS:CLSD)

$ 1.15 0 (0%) Market Cap: 85.96 Mil Enterprise Value: 57.46 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 64/100

Q4 2023 Clearside Biomedical Inc Earnings Call Transcript
Mar 12, 2024

$1.64 (-18.81%)

Earnings
Q3 2023 Clearside Biomedical Inc Earnings Call Transcript
Nov 13, 2023

$0.97 (+0.18%)

Earnings
Clearside Biomedical Inc at HC Wainwright Ophthalmology Virtual Conference Transcript
Aug 16, 2023
Q2 2023 Clearside Biomedical Inc Earnings Call Transcript
Aug 14, 2023

$1.06 (+0.95%)

Earnings
Clearside Biomedical Inc at JMP Securities Life Sciences Conference Transcript
May 16, 2023
Q1 2023 Clearside Biomedical Inc Earnings Call Transcript
May 11, 2023

$1.08 (-6.90%)

Earnings
Clearside Biomedical Inc at Needham Healthcare Conference (Virtual) Transcript
Apr 19, 2023
Q4 2022 Clearside Biomedical Inc Earnings Call Transcript
Mar 09, 2023

$1.19 (-3.25%)

Earnings
Clearside Biomedical Inc OASIS Extension Study Results Call Transcript
Feb 02, 2023
Clearside Biomedical Inc at Piper Sandler Healthcare Conference Transcript
Dec 01, 2022
Clearside Biomedical Inc at Stifel Healthcare Conference Transcript
Nov 16, 2022
Q3 2022 Clearside Biomedical Inc Earnings Call Transcript
Nov 09, 2022

$1.28 (-8.57%)

Earnings
Q2 2022 Clearside Biomedical Inc Earnings Call Transcript
Aug 09, 2022

$1.61 (-1.83%)

Earnings
Clearside Biomedical Inc at JMP Securities Life Sciences Conference Transcript
Jun 15, 2022
Q1 2022 Clearside Biomedical Inc Earnings Call Transcript
May 11, 2022

$1.45 (-7.64%)

Earnings
Clearside Biomedical Inc at Needham Healthcare Conference (Virtual) Transcript
Apr 13, 2022
Q4 2021 Clearside Biomedical Inc Earnings Call Transcript
Mar 10, 2022

$1.35 (-9.40%)

Earnings
Clearside Biomedical Inc OASIS Trial Update Call Transcript
Dec 21, 2021
Q3 2021 Clearside Biomedical Inc Earnings Call Transcript
Nov 10, 2021

$4.95 (-3.13%)

Earnings
Q2 2021 Clearside Biomedical Inc Earnings Call Transcript
Aug 10, 2021

$4.94 (-5.18%)

Earnings
Clearside Biomedical Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript
Jun 23, 2021
Clearside Biomedical Inc at JMP Securities Life Sciences Virtual Conference Transcript
Jun 16, 2021
Q1 2021 Clearside Biomedical Inc Earnings Call Transcript
May 17, 2021

$2.37 (-0.42%)

Earnings
Q4 2020 Clearside Biomedical Inc Earnings Call Transcript
Mar 10, 2021

$3.52 (+8.31%)

Earnings
Q3 2020 Clearside Biomedical Inc Earnings Call Transcript
Nov 10, 2020

$1.53 (+12.50%)

Earnings
Q2 2020 Clearside Biomedical Inc Earnings Call Transcript
Aug 10, 2020

$1.79 (+1.70%)

Earnings
Clearside Biomedical, Inc. - Special Call Transcript
Apr 28, 2020
Clearside Biomedical Inc at Needham Healthcare Conference Transcript
Apr 15, 2020
Q4 2019 Clearside Biomedical Inc Earnings Call Transcript
Mar 11, 2020

$2.59 (+3.60%)

Earnings
Clearside Biomedical Inc at JPMorgan Healthcare Conference Transcript
Jan 16, 2020
Q3 2019 Clearside Biomedical Inc Earnings Call Transcript
Nov 06, 2019

$1.21 (-4.72%)

Earnings
Q2 2019 Clearside Biomedical Inc Earnings Call Transcript
Aug 07, 2019

$1 (-1.96%)

Earnings
Clearside Biomedical Inc at UBS Global Healthcare Conference Transcript
May 22, 2019
Q1 2019 Clearside Biomedical Inc Earnings Call Transcript
May 08, 2019

$1.21 (-0.82%)

Earnings
Q4 2018 Clearside Biomedical Inc Earnings Call Transcript
Mar 12, 2019

$1.4 (+9.37%)

Earnings

Q1 2023 Clearside Biomedical Inc Earnings Call Transcript

May 11, 2023 / 12:30PM GMT

Release Date Price: $1.08 (-6.90%)

Transcript 10-Q8-K

Operator

Good day, and thank you for standing by. Welcome to the Clearside Biomedical quarter 2023 financial results and corporate update call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to turn the conference over to your speaker today, Jenny Kobin, Clearside Investor Relations.

Jenny Kobin

Clearside Biomedical, Inc. - IR

Good morning, everyone, and thank you for joining us on the call today. Before we begin, I would like to remind you that during today's call, we will be making certain forward-looking statements. Various remarks that we make during this call and about the company's future expectations, plans, and prospects constitute forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the risk factors section of our annual report on Form 10-K for the year ended December 31, 2022, and our other SEC

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.